Mereo BioPharma Group plc (MREO)
Mereo BioPharma Group plc (MREO) Insider Trading
Directors, officers and holders of more than 10% of MREO report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 75 transactions on file: 0 with code P, 1 with code S and 49 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Jacquet Pierre | Director | A Award | 66,000 | Not measured | Not measured |
| Feb 26, 2026 | Ekblom Anders | Director | A Award | 133,560 | Not measured | Not measured |
| Feb 26, 2026 | Ekblom Anders | Director | A Award | 66,000 | Not measured | Not measured |
| Feb 26, 2026 | Shames Daniel | Director | A Award | 96,163 | Not measured | Not measured |
| Feb 26, 2026 | Shames Daniel | Director | A Award | 66,000 | Not measured | Not measured |
| Feb 26, 2026 | Bender Jeremy | Director | A Award | 117,533 | Not measured | Not measured |
| Feb 26, 2026 | Bender Jeremy | Director | A Award | 66,000 | Not measured | Not measured |
| Feb 26, 2026 | PAKIANATHAN DEEPIKA | Director | A Award | 66,000 | Not measured | Not measured |
| Feb 26, 2026 | WYZGA MICHAEL S | Director | A Award | 66,000 | Not measured | Not measured |
| Feb 26, 2026 | Jenkins Annalisa | Director | A Award | 106,848 | Not measured | Not measured |
| Feb 26, 2026 | Jenkins Annalisa | Director | A Award | 66,000 | Not measured | Not measured |
| Feb 26, 2026 | Yoskowitz Marc J | Director | A Award | 96,163 | Not measured | Not measured |
| Feb 26, 2026 | Yoskowitz Marc J | Director | A Award | 66,000 | Not measured | Not measured |
| Feb 26, 2026 | Jacquet Pierre | Director | A Award | 106,848 | Not measured | Not measured |
| Feb 1, 2026 | Fox Christine Ann | Chief Financial Officer | A Award | 280,000 | Not measured | Not measured |
| Feb 1, 2026 | Lewicki John A. | Chief Scientific Officer | A Award | 139,913 | Not measured | Not measured |
| Feb 1, 2026 | Lewicki John A. | Chief Scientific Officer | A Award | 46,637 | Not measured | Not measured |
| Feb 1, 2026 | Lewicki John A. | Chief Scientific Officer | A Award | 145,000 | Not measured | Not measured |
| Feb 1, 2026 | Hughes-Wilson Alexandra | See Remarks | A Award | 183,750 | Not measured | Not measured |
| Feb 1, 2026 | Hughes-Wilson Alexandra | See Remarks | A Award | 61,250 | Not measured | Not measured |
| Feb 1, 2026 | Hughes-Wilson Alexandra | See Remarks | A Award | 195,000 | Not measured | Not measured |
| Feb 1, 2026 | Sermon Charles | General Counsel | A Award | 315,750 | Not measured | Not measured |
| Feb 1, 2026 | Sermon Charles | General Counsel | A Award | 105,250 | Not measured | Not measured |
| Feb 1, 2026 | Sermon Charles | General Counsel | A Award | 295,000 | Not measured | Not measured |
| Feb 1, 2026 | Scots-Knight Denise | Chief Executive Officer | A Award | 1,035,000 | Not measured | Not measured |
| Feb 1, 2026 | Scots-Knight Denise | Chief Executive Officer | A Award | 345,000 | Not measured | Not measured |
| Feb 1, 2026 | Scots-Knight Denise | Chief Executive Officer | A Award | 480,000 | Not measured | Not measured |
| Feb 1, 2026 | Fox Christine Ann | Chief Financial Officer | A Award | 315,750 | Not measured | Not measured |
| Feb 1, 2026 | Fox Christine Ann | Chief Financial Officer | A Award | 105,250 | Not measured | Not measured |
| Feb 5, 2025 | Bender Jeremy | Director | A Award | 55,000 | Not measured | Not measured |
| Feb 5, 2025 | PAKIANATHAN DEEPIKA | Director | A Award | 55,000 | Not measured | Not measured |
| Feb 5, 2025 | Yoskowitz Marc J | Director | A Award | 13,719 | Not measured | Not measured |
| Feb 5, 2025 | Yoskowitz Marc J | Director | A Award | 55,000 | Not measured | Not measured |
| Feb 5, 2025 | Jacquet Pierre | Director | A Award | 15,243 | Not measured | Not measured |
| Feb 5, 2025 | Shames Daniel | Director | A Award | 13,719 | Not measured | Not measured |
| Feb 5, 2025 | Jenkins Annalisa | Director | A Award | 55,000 | Not measured | Not measured |
| Feb 5, 2025 | Jenkins Annalisa | Director | A Award | 15,243 | Not measured | Not measured |
| Feb 5, 2025 | Jacquet Pierre | Director | A Award | 55,000 | Not measured | Not measured |
| Feb 5, 2025 | Shames Daniel | Director | A Award | 55,000 | Not measured | Not measured |
| Feb 5, 2025 | WYZGA MICHAEL S | Director | A Award | 30,487 | Not measured | Not measured |
| Feb 5, 2025 | WYZGA MICHAEL S | Director | A Award | 55,000 | Not measured | Not measured |
| Feb 5, 2025 | Ekblom Anders | Director | A Award | 19,054 | Not measured | Not measured |
| Feb 5, 2025 | Ekblom Anders | Director | A Award | 55,000 | Not measured | Not measured |
| Feb 5, 2025 | Bender Jeremy | Director | A Award | 16,768 | Not measured | Not measured |
| Jan 25, 2025 | Fox Christine Ann | Chief Financial Officer | A Award | 262,000 | Not measured | Not measured |
| Jan 25, 2025 | Sermon Charles | General Counsel | A Award | 262,000 | Not measured | Not measured |
| Jan 25, 2025 | Hughes-Wilson Alexandra | See Remarks | A Award | 154,000 | Not measured | Not measured |
| Jan 25, 2025 | Scots-Knight Denise | Chief Executive Officer | A Award | 825,000 | Not measured | Not measured |
| Jan 25, 2025 | Lewicki John A. | Chief Scientific Officer | A Award | 116,000 | Not measured | Not measured |
| Sep 13, 2024 | Hughes-Wilson Alexandra | See Remarks | S Sale | 16,304 | $4.22 | $68,819 |
The full Form 4 history is on the MREO company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.